|
Index of reports
> Cases with Pneumocystis Jiroveci Pneumonia (98)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include pneumocystis jiroveci pneumonia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 98 Next >>
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Cyclophosphamide
Cyclophosphamide
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
Etoposide
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-08-09
Patient: male
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 5 mg, uid/qd
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2010-04-20
End date: 2010-06-24
Prednisolone
Indication: Rheumatoid Arthritis
Prograf
Indication: Interstitial Lung Disease
Prograf
Dosage: 0.5 mg, tid
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2010-06-15
End date: 2010-06-24
Other drugs received by patient: Lansoprazole; Lansoprazole
Possible Prednisolone side effects in 74 year old male
Reported by a physician from Japan on 2012-08-07
Patient: 74 year old male, weighing 50.0 kg (110.0 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 50 mg, unk
Administration route: Oral
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-10-18
End date: 2011-12-30
Romiplostim - KHK
Dosage: 1 mug/kg, qd
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-11-21
End date: 2011-11-21
Possible Prednisolone side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-07-31
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Lung Infiltration, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650mg/m2
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: 25 mg/m2, unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, unk
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, unk
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: Hodgkin's Disease
Possible Prednisolone side effects in
Reported by a physician from Korea, Republic of on 2012-07-30
Patient:
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 6.5 unk, unk
Start date: 2011-12-20
End date: 2012-06-26
Melphalan Hydrochloride
Dosage: 9 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-09-18
End date: 2011-09-21
Melphalan Hydrochloride
Dosage: 9 mg/m2, unk
Start date: 2011-10-31
End date: 2011-11-03
Prednisolone
Dosage: 45 mg/m2, unk
Start date: 2011-12-20
End date: 2012-06-26
Prednisolone
Dosage: 60 mg/m2, unk
Start date: 2011-10-31
End date: 2011-11-03
Prednisolone
Dosage: 60 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-09-18
End date: 2011-09-21
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-09-08
End date: 2011-10-20
Velcade
Dosage: 1.0 mg/m2, unk
Start date: 2011-10-31
End date: 2012-06-21
Possible Prednisolone side effects in 73 year old male
Reported by a physician from Japan on 2012-07-27
Patient: 73 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Intentional Drug Misuse
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 25 mg, bid, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Prograf
Dosage: 1 mg, uid/qd, oral : 1.5 mg, uid/qd, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-06-11
End date: 2008-11-18
Prograf
Dosage: 1 mg, uid/qd, oral : 1.5 mg, uid/qd, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-11-19
Rheumatrex
Dosage: oral
Administration route: Oral
Indication: Rheumatoid Arthritis
End date: 2009-01-28
Other drugs received by patient: Celecoxib
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-19
Patient: female
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
End date: 2012-07-03
Simponi
Indication: Rheumatoid Arthritis
Start date: 2011-11-01
Simponi
Start date: 2012-06-05
End date: 2012-06-05
Other drugs received by patient: Celebrex
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Mycophenolate Mofetil
Indication: Renal Transplant
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Rituximab
Dosage: unk ukn, unk
Other drugs received by patient: Insulin
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Mycophenolate Mofetil
Indication: Renal Transplant
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Rituximab
Dosage: unk ukn, unk
Other drugs received by patient: Insulin
Possible Prednisolone side effects in 16 year old female
Reported by a physician from Japan on 2012-07-16
Patient: 16 year old female
Reactions: Pneumocystis Jiroveci Pneumonia, Drug Ineffective
Drug(s) suspected as cause:
Cyclosporine
Indication: Juvenile Arthritis
Start date: 2006-01-01
Etanercept
Indication: Juvenile Arthritis
End date: 2007-08-01
Methylprednisolone
Start date: 2006-01-01
End date: 2006-01-01
Methylprednisolone
Indication: Juvenile Arthritis
Start date: 2006-01-01
End date: 2006-01-01
Prednisolone
Indication: Juvenile Arthritis
Start date: 2006-01-01
Remicade
Indication: Juvenile Arthritis
Remicade
Indication: Histiocytosis Haematophagic
Rheumatrex
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2006-11-01
End date: 2007-08-01
Tacrolimus
Indication: Juvenile Arthritis
Start date: 2006-01-01
Possible Prednisolone side effects in
Reported by a physician from Korea, Republic of on 2012-07-16
Patient:
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 9 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-09-18
End date: 2011-09-21
Melphalan Hydrochloride
Dosage: 6.5 unk, unk
Start date: 2011-12-20
End date: 2012-06-26
Melphalan Hydrochloride
Dosage: 9 mg/m2, unk
Start date: 2011-10-31
End date: 2011-11-03
Prednisolone
Dosage: 60 mg/m2, unk
Start date: 2011-10-31
End date: 2011-11-03
Prednisolone
Dosage: 45 mg/m2, unk
Start date: 2011-12-20
End date: 2012-06-26
Prednisolone
Dosage: 60 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-09-18
End date: 2011-09-21
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-09-08
End date: 2011-10-20
Velcade
Dosage: 1.0 mg/m2, unk
Start date: 2011-10-31
End date: 2012-06-21
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-07-16
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Intentional Drug Misuse
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Rheumatoid Arthritis
Prograf
Dosage: 1 mg, uid/qd
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-06-11
End date: 2008-11-18
Prograf
Dosage: 1.5 mg, uid/qd
Administration route: Oral
Start date: 2008-11-19
Rheumatrex
Dosage: unk
Administration route: Oral
Indication: Rheumatoid Arthritis
End date: 2009-01-28
Other drugs received by patient: Celebrex
Possible Prednisolone side effects in 16 year old female
Reported by a physician from Japan on 2012-07-13
Patient: 16 year old female
Reactions: Pneumocystis Jiroveci Pneumonia, Drug Ineffective
Drug(s) suspected as cause:
Cyclosporine
Indication: Juvenile Arthritis
Start date: 2006-01-01
Etanercept
Indication: Juvenile Arthritis
End date: 2007-08-01
Methylprednisolone
Start date: 2006-01-01
End date: 2006-01-01
Methylprednisolone
Indication: Juvenile Arthritis
Start date: 2006-01-01
End date: 2006-01-01
Prednisolone
Indication: Juvenile Arthritis
Start date: 2006-01-01
Remicade
Indication: Juvenile Arthritis
Remicade
Indication: Histiocytosis Haematophagic
Rheumatrex
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2006-11-01
End date: 2007-08-01
Tacrolimus
Indication: Juvenile Arthritis
Start date: 2006-01-01
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-11
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Start date: 2011-01-13
Doxorubicin HCL
Indication: Lymphoma
Start date: 2011-01-13
Mabthera
Indication: Lymphoma
Start date: 2011-01-13
Prednisolone
Dosage: 40 mg/m2;
Administration route: Oral
Indication: Lymphoma
Start date: 2011-01-13
End date: 2011-01-17
Vincristine
Indication: Lymphoma
Start date: 2011-01-13
Other drugs received by patient: Nexium
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-10
Patient: female
Reactions: Pneumocystis Jiroveci Pneumonia, Hypoxia, Blood Beta-D-Glucan Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Indication: Rheumatoid Arthritis
Start date: 2010-07-14
End date: 2010-09-08
Prednisolone
Indication: Product Used FOR Unknown Indication
Promacta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Methotrexate; Prednisolone; Methotrexate; Prednisolone
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-10
Patient: female, weighing 37.5 kg (82.5 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, Ileus Paralytic
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 120 mg/m2;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-24
End date: 2011-08-25
Bendamustine Hydrochloride
Dosage: 120 mg/m2;
Start date: 2011-09-13
Cyclophosphamide
Dosage: 490 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Prednisolone
Dosage: 80 milligram;
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Rituximab
Dosage: 490 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Vincristine Sulfate
Dosage: .9 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Other drugs received by patient: Palonosetron Hydrochloride; Granisetron Hydrochloride; Cefmetazole Sodium; Tazobactam; Granisetron Hydrochloride; Platelets
Possible Prednisolone side effects in female
Reported by a individual with unspecified qualification from Japan on 2012-07-06
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Diarrhoea, Interstitial Lung Disease, Pneumonia Pneumococcal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actemra
Start date: 2009-11-20
End date: 2011-02-07
Actemra
Start date: 2011-06-01
End date: 2011-06-01
Actemra
Indication: Rheumatoid Arthritis
Start date: 2009-07-21
End date: 2009-07-21
Actemra
Start date: 2011-04-15
End date: 2011-04-15
Methotrexate
Dosage: form: peroral agent
Administration route: Oral
Start date: 2008-03-14
End date: 2008-05-15
Methotrexate
Dosage: form: peroral agent
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-01-01
End date: 2008-03-14
Methotrexate
Dosage: form: peroral agent
Administration route: Oral
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Other drugs received by patient: Loxonin; Mucosta; Omeprazole; Risedronate Sodium
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-07-05
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 2.5 mg, bid
Administration route: Oral
Prograf
Indication: Rheumatoid Arthritis
Rheumatrex
Dosage: unk
Administration route: Oral
End date: 2009-01-28
Other drugs received by patient: Celebrex
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-02
Patient: female, weighing 37.5 kg (82.5 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, Ileus Paralytic
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 120 mg/m2;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-24
End date: 2011-08-25
Bendamustine Hydrochloride
Dosage: 120 mg/m2;
Start date: 2011-09-13
Cyclophosphamide
Dosage: 490 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Prednisolone
Dosage: 80 milligram;
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Rituximab
Dosage: 490 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Vincristine Sulfate
Dosage: .9 milligram;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-26
Other drugs received by patient: Granisetron Hydrochloride; Palonosetron Hydrochloride; Granisetron Hydrochloride; Tazobactam; Cefmetazole Sodium; Piperacillin Sodium W / Tazobactam
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-06-27
Patient: female, weighing 33.0 kg (72.6 pounds)
Reactions: Histiocytosis Haematophagic, Gastric Ulcer Haemorrhage, Shock Haemorrhagic, Device Related Infection, Staphylococcal Sepsis, Oral Herpes, Haemothorax, Pneumocystis Jiroveci Pneumonia, Pneumothorax, Juvenile Arthritis
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Actemra
Start date: 2009-09-09
Actemra
Indication: Juvenile Arthritis
Start date: 2009-04-21
End date: 2011-12-28
Actemra
Start date: 2012-01-04
End date: 2012-01-26
Actemra
Start date: 2012-02-10
End date: 2012-02-24
Actemra
Start date: 2009-07-28
End date: 2009-08-26
Cyclosporine
Indication: Histiocytosis Haematophagic
Start date: 2012-02-27
End date: 2012-03-11
Cyclosporine
Indication: Juvenile Arthritis
Start date: 2011-12-30
End date: 2012-01-05
Dexamethasone
Start date: 2012-01-04
End date: 2012-01-04
Dexamethasone
Start date: 2009-02-16
End date: 2009-04-13
Dexamethasone
Indication: Juvenile Arthritis
Start date: 2009-02-05
End date: 2009-02-05
Dexamethasone
Start date: 2009-02-09
End date: 2009-02-09
Dexamethasone
Start date: 2009-02-12
End date: 2009-02-12
Methylprednisolone
Start date: 2009-01-26
End date: 2009-01-28
Methylprednisolone
Dosage: uncertain dosage and three cool
Start date: 2011-01-01
End date: 2011-01-01
Methylprednisolone
Dosage: uncertain dosage and three cool
Indication: Juvenile Arthritis
Start date: 2008-01-01
End date: 2008-01-01
Methylprednisolone
Start date: 2009-02-02
End date: 2009-02-04
Methylprednisolone
Start date: 2011-12-30
End date: 2012-01-01
Methylprednisolone
Start date: 2012-01-06
End date: 2012-01-08
Methylprednisolone
Start date: 2012-01-13
End date: 2012-01-15
Methylprednisolone
Start date: 2012-02-27
End date: 2012-02-29
Methylprednisolone
Start date: 2009-01-19
End date: 2009-01-21
Prednisolone
Administration route: Oral
Start date: 2008-01-01
End date: 2009-01-01
Prednisolone
Administration route: Oral
Start date: 2009-06-02
End date: 2009-06-08
Prednisolone
Administration route: Oral
Start date: 2009-08-12
End date: 2009-08-18
Prednisolone
Administration route: Oral
Start date: 2010-01-06
End date: 2010-02-02
Prednisolone
Administration route: Oral
Start date: 2011-01-01
End date: 2011-12-27
Prednisolone
Administration route: Oral
Start date: 2012-01-09
End date: 2012-01-12
Prednisolone
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-26
Prednisolone
Administration route: Oral
Start date: 2009-06-30
End date: 2009-06-30
Prednisolone
Administration route: Oral
Start date: 2011-12-28
End date: 2011-12-29
Prednisolone
Administration route: Oral
Start date: 2012-01-23
End date: 2012-02-05
Prednisolone
Administration route: Oral
Start date: 2009-01-29
End date: 2009-02-01
Prednisolone
Administration route: Oral
Start date: 2009-06-09
End date: 2009-06-15
Prednisolone
Administration route: Oral
Start date: 2009-06-16
End date: 2009-06-22
Prednisolone
Administration route: Oral
Start date: 2009-07-01
End date: 2009-07-13
Prednisolone
Administration route: Oral
Start date: 2012-01-02
End date: 2012-01-05
Prednisolone
Administration route: Oral
Start date: 2009-08-26
End date: 2009-09-23
Prednisolone
Administration route: Oral
Start date: 2009-09-24
End date: 2009-10-20
Prednisolone
Administration route: Oral
Start date: 2009-11-18
End date: 2010-01-05
Prednisolone
Administration route: Oral
Start date: 2012-02-13
End date: 2012-02-19
Prednisolone
Administration route: Oral
Start date: 2009-01-22
End date: 2009-01-25
Prednisolone
Administration route: Oral
Start date: 2009-08-19
End date: 2009-08-25
Prednisolone
Administration route: Oral
Start date: 2009-10-21
End date: 2009-11-17
Prednisolone
Administration route: Oral
Start date: 2012-02-06
End date: 2012-02-12
Prednisolone
Administration route: Oral
Start date: 2009-02-05
End date: 2009-02-08
Prednisolone
Administration route: Oral
Start date: 2009-02-09
End date: 2009-05-28
Prednisolone
Administration route: Oral
Start date: 2009-05-29
End date: 2009-06-01
Prednisolone
Administration route: Oral
Start date: 2009-07-28
End date: 2009-08-11
Prednisolone
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Prednisolone
Administration route: Oral
Start date: 2012-01-21
End date: 2012-01-22
Prednisolone
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2008-01-01
End date: 2008-01-01
Prednisolone
Administration route: Oral
Start date: 2009-06-23
End date: 2009-06-29
Prednisolone
Administration route: Oral
Start date: 2010-02-03
End date: 2011-01-01
Prednisolone
Administration route: Oral
Start date: 2009-07-14
End date: 2009-07-27
Prednisolone
Administration route: Oral
Start date: 2012-01-16
End date: 2012-01-20
Tacrolimus
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2009-02-09
End date: 2009-02-16
Tacrolimus
Administration route: Oral
Start date: 2009-05-22
Tacrolimus
Administration route: Oral
Start date: 2012-01-23
End date: 2012-02-19
Tacrolimus
Administration route: Oral
Start date: 2009-02-17
End date: 2009-02-19
Tacrolimus
Administration route: Oral
Start date: 2012-01-16
End date: 2012-01-20
Tacrolimus
Administration route: Oral
Start date: 2009-02-20
End date: 2009-05-21
Other drugs received by patient: Depakene; Adalat CC; Enalapril Maleate; Ibruprofen; Famotidine; Colchicine; Actonel; Alfarol; Methotrexate; Foliamin; Clobazam; Colchicine
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-06-25
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Bronchopulmonary Aspergillosis, Cytomegalovirus Enterocolitis, Drug Ineffective
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 25 mg, unknown/d
Administration route: Oral
End date: 2012-06-01
Prednisolone
Dosage: unk
Administration route: Oral
Indication: Colitis Ulcerative
Start date: 2009-12-22
Prograf
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Colitis Ulcerative
Start date: 2012-03-07
End date: 2012-05-13
Remicade
Dosage: unk
Indication: Colitis Ulcerative
Start date: 2012-02-14
End date: 2012-02-28
Other drugs received by patient: Pentasa; Lipitor; Evista; Famotidine; Lansoprazole; Pentasa; Bitsan; Norvasc
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-06-14
Patient: 49 year old male
Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Cyclophosphamide
Doxorubicin HCL
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-06-13
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Hyperlipidaemia, Peripheral Arterial Occlusive Disease, Arrhythmia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actemra
Dosage: dosage is uncertain.
Indication: Rheumatoid Arthritis
Start date: 2011-06-21
End date: 2012-02-02
Prednisolone
Dosage: 2mg ,10mg
Administration route: Oral
Indication: Rheumatoid Vasculitis
Start date: 2003-01-01
Rheumatrex
Administration route: Oral
Rheumatrex
Administration route: Oral
Indication: Rheumatoid Vasculitis
Start date: 2003-08-01
Rheumatrex
Administration route: Oral
Other drugs received by patient: Azulfidine; Aspara-CA; Actonel; Cytotec; Foliamin; Rimatil; Marzulene-S; Miya BM; Rabeprazole Sodium; Mobic; Onealfa; Voltaren
Possible Prednisolone side effects in 64 year old female
Reported by a physician from Japan on 2012-06-12
Patient: 64 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Gastrointestinal Haemorrhage, Gastritis Erosive, Constipation, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Ileus, Oedema, Gastrooesophageal Reflux Disease, Renal Failure Acute, Decreased Appetite, White Blood Cell Count Decreased, Vomiting, Stomatitis, Nausea, Anaemia, Febrile Neutropenia, Diarrhoea, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Marzulene-S
Dosage: 3 packs
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-19
End date: 2009-08-18
Omeprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-19
End date: 2009-05-25
Oncovin
Dosage: 20may09-20may09 27may09-27may09 03jun09-03jun09 10jun09-10jun09 14aug09-14aug09
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-05-20
End date: 2009-08-14
Prednisolone
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-27
End date: 2009-06-16
Sprycel
Dosage: therapy interrupted on 04sep09,restarted on 24sep09.
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-05-27
End date: 2009-10-09
Other drugs received by patient: Granisetron HCL; Doxorubicin HCL; Leucovorin Calcium; Uralyt; Bactrim; Potassium Citrate; Cyclophosphamide; Sulbactam Sodium; Acetazolamide; Gasmotin; Sodium Citrate; Diart; Methylprednisolone Sodium Succinate; Neuquinon; Cytarabine; Oren-Gedoku-TO; Trimethoprim; Dexamethasone Sodium Phosphate; Ampicillin Sodium; Mosapride Citrate; Granisetron HCL; Methotrexate; Amikacin Sulfate; Carbazochrome Sodium Sulfonate; Amino Acid INJ; Miya-BM; Aldactone; Maxipime
Possible Prednisolone side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on d8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 35mg/m2,on d1 for escalated cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
Indication: Hodgkin's Disease
Prednisolone
Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day1-7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on d8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-06-08
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-06-08
Patient: female, weighing 33.0 kg (72.6 pounds)
Reactions: Histiocytosis Haematophagic, Gastric Ulcer Haemorrhage, Shock Haemorrhagic, Device Related Infection, Staphylococcal Sepsis, Oral Herpes, Haemothorax, Pneumocystis Jiroveci Pneumonia, Pneumothorax, Juvenile Arthritis
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Actemra
Start date: 2012-01-04
End date: 2012-01-26
Actemra
Start date: 2012-02-10
End date: 2012-02-24
Actemra
Indication: Juvenile Arthritis
Start date: 2009-04-21
End date: 2011-12-28
Actemra
Start date: 2009-09-09
Actemra
Start date: 2009-07-28
End date: 2009-08-26
Cyclosporine
Indication: Juvenile Arthritis
Start date: 2011-12-30
End date: 2012-01-05
Cyclosporine
Indication: Histiocytosis Haematophagic
Start date: 2012-02-27
End date: 2012-03-11
Dexamethasone
Indication: Juvenile Arthritis
Start date: 2012-01-04
End date: 2012-01-04
Methylprednisolone Sodium Succinate
Start date: 2012-02-27
End date: 2012-02-29
Methylprednisolone Sodium Succinate
Indication: Juvenile Arthritis
Start date: 2011-12-30
End date: 2012-01-01
Methylprednisolone Sodium Succinate
Start date: 2012-01-06
End date: 2012-01-08
Methylprednisolone Sodium Succinate
Start date: 2012-01-13
End date: 2012-01-15
Prednisolone
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-26
Prednisolone
Administration route: Oral
Start date: 2012-01-02
End date: 2012-01-05
Prednisolone
Administration route: Oral
Start date: 2012-01-21
End date: 2012-01-22
Prednisolone
Administration route: Oral
Start date: 2012-02-13
End date: 2012-02-19
Prednisolone
Administration route: Oral
Start date: 2012-01-16
End date: 2012-01-20
Prednisolone
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2011-12-28
End date: 2011-12-29
Prednisolone
Administration route: Oral
Start date: 2012-01-09
End date: 2012-01-12
Prednisolone
Administration route: Oral
Start date: 2012-01-23
End date: 2012-02-05
Prednisolone
Administration route: Oral
Start date: 2012-02-06
End date: 2012-02-12
Tacrolimus
Administration route: Oral
Indication: Juvenile Arthritis
Start date: 2012-01-16
End date: 2012-01-20
Tacrolimus
Administration route: Oral
Start date: 2012-01-23
End date: 2012-02-19
Other drugs received by patient: Clobazam; Alfarol; Actonel; Enalapril Maleate; Depakene; Methotrexate; Foliamin; Ibruprofen; Adalat CC; Colchicine; Colchicine
Page 1 Next >>
|
